The most comprehensive and up-to-date site for information on institutional and agency responses to COVID-19 can be found on the Council on Governmental Relations (COGR) site. Below, we add additional information on how to contact Division of Research (DOR) staff and agency-specific information that is particularly relevant to University of Houston (UH) researchers.
Biweekly VPR Communications
March 2020 COVID-19 Updates
April 2020 COVID-19 Updates
May 2020 COVID-19 Updates
Contact Information for DOR Offices
To contact Research Integrity and Oversight (RIO), Office of Contracts and Grants (OCG), Animal Care Operation (ACO), or DOR Business Operations (BizOps) use the following e-mail addresses:
- ACO: firstname.lastname@example.org
- BizOps: email@example.com
If you wish to speak to a staff member directly, please call their office phone number. If they are unable to answer your call or if they work from home, they will receive an e-mail through Outlook with the phone number you used to call them. Staff members will return your call within two hours during the peak work hours 9:00 am and 4:00 pm, or, if the call falls outside of the peak work hours, the next business day.
There are significant security concerns associated with information sharing through collaboration tools. We require that you use only UH officially licensed applications for all UH related business, not trial versions or personal licenses to make sure that the appropriate security controls can be implemented and that there are UH-accessible logs for the sessions. UH has licenses for following platforms (for additional restrictions when online platforms are used for Human Subject research that require HIPAA or other healthcare privacy compliance, see here):
- Microsoft Teams using the UH license. It is the preferred collaboration tool. Tips are available here.
- Microsoft Skype for Business (SFB) using the UH license. Tips are available here.
- Zoom using the UH license. Information on how to obtain a UH license can be found here. Tips are available here.
Responses to COVID-19
- M-20-11: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19)
- M-20-17: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations
- M-20-18: Managing Federal Contract Performance Issues Associated with the Novel Coronavirus (COVID-19)
- National Institutes of Health (NIH)
- Requests for extensions are evaluated on a case-by-case basis and should only be submitted by institutions which have operations impacted by the virus. Note that UH is operating normally at this point.
- NIH implemented OMB Memorandum M-20-17. Notice NOT-OD-20-086 clarifies the use of grant funding to charge salaries and benefits during periods when no work is performed due to the effect of COVID-19. NIH Implemented the memorandum by issuing several notices.
- OT-OD-20-087 - Guidance outlining the flexibilities available to recipients conducting NIH-funded clinical trials and human subject studies.
- NOT-OD-20-082 - Late Proposal Application.
- NOT-OD-20-083 - High-level questions.
- NOT-OD-20-086 - For COVID-19 Short Term Flexibilities.
- NOT-OD-20-091 - Application deadlines: all grant applications submitted late for due dates between March 9, 2020, and May 1, 2020, will be accepted through May 1, 2020.
- Health and Human Services
- Administration for Children and Families: Note the requirement to contact the program officer when utilizing any of the flexibilities offered.
- Substance Abuse and Mental Health Service Administration (SAMHSA): COVID-19 information about flexibilities available to SAMHSA discretionary grant recipients.
- National Science Foundation
- Department of Energy
- Department of Defense
- FAQs for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19).
- U.S. Army Medical Research Acquisition Activity and their FAQs.
- Congressionally Mandated Medical Research Program (CDMRP):
- Amyotrophic Lateral Sclerosis Research Program (ALSRP), Autism Research Program (ARP), and Ovarian Cancer Research Program (OCRP) have extended the pre-application submission deadlines.
- DOD implemented OMB Memorandum M-20-17. Details can be found here.
- National Oceanic and Atmospheric Administration (NOAA)
- Department of Education
- Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for IES Grantees
- National Endowment for the Arts
- National Endowment for the Humanities
- National Aeronautics and Space Administration
- Institute of Museum and Library Services
- Several of their application deadlines have been changed.
- American Heart Association
- Visit the FAQ site for guidance on current grants and cancellations of their programs.
- Funding opportunities that were not cancelled are listed here.
- Grantees should contact program managers (Patty Moore, Academic Research; Rosemary French, Product Development; and Ramona Magid, Prevention) with questions about COVID-19’s effect on individual grant projects. CPRIT has also created a dedicated email (firstname.lastname@example.org) for grantee questions.
Other Useful Sites
- COGR's FAQs and Resources on COVID-19's Impact to Federal Awards.
- InfoEd provides open access to funding opportunities related to COVID-19.
- APLU maintains a website on the U.S. Government COVID-19 Response.
- Johns Hopkins University maintains a funding opportunity site that is frequently updated.
- Eva Garland Consulting, LLC maintains a list of COVID-19 Funding Opportunities and you can sign up for being notified of new opportunities on their site.